NON–QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENTNon–qualified Stock Option Inducement Award Agreement • March 20th, 2019 • Axogen, Inc. • Electromedical & electrotherapeutic apparatus • Minnesota
Contract Type FiledMarch 20th, 2019 Company Industry JurisdictionThis Non–Qualified Stock Option Inducement Award Agreement (the “Agreement”), effective as of this 7th day of January, 2019 (the “Effective Date”), by and between AxoGen, Inc., a Minnesota corporation (the “Company”), and Chris Crisman (“Optionee”) is made in connection with the Optionee’s entry into employment within the meaning of Rule 5635(c)(4) of the NASDAQ Listing Rules. If and to the extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of any employment, consulting or similar services agreement between the Optionee and the Company as may be in effect (the “Service Agreement”), the Service Agreement shall control, and this Agreement shall be deemed to be modified accordingly. Capitalized terms used but not defined herein shall have the meanings set forth in that certain Employment Agreement by and between the Company and the Optionee dated as of January 7, 2019 (the “Employment Agreement”).
OCUGEN, INC. NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENTNon-Qualified Stock Option Inducement Award Agreement • February 28th, 2023 • Ocugen, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 28th, 2023 Company IndustryTHIS NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENT (“Agreement”) is made and entered into as of _____________ (the “Grant Date”), by and between Ocugen, Inc., a Delaware corporation (the “Company”), and ________________, an individual (the “Optionee”).
AGENUS INC. NON-QUALIFIED STOCK OPTION INDUCEMENT AWARD AGREEMENTNon-Qualified Stock Option Inducement Award Agreement • August 3rd, 2015 • Agenus Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 3rd, 2015 Company Industry JurisdictionThis Non-Qualified Stock Option Inducement Award Agreement (this “Agreement”), effective as of June 17, 2015 between Agenus Inc. (the “Company”) and C. Evan Ballantyne (the “Participant”), is made pursuant to the letter agreement dated June 8, 2015 between the Company and the Participant and is an inducement material to the Participant’s entry into employment within the meaning of NASDAQ Listing Rule 5635(c)(4). The term “Company” shall include any other business venture in which the Company has a direct or indirect significant interest, as determined by the Board of Directors of the Company (the “Board”) in its sole discretion.